Narrative updates are currently in beta.

Back to narrative

Update shared on04 Aug 2025

Fair value Increased 8.43%
AnalystConsensusTarget's Fair Value
US$157.56
10.6% undervalued intrinsic discount
14 Aug
US$140.81
Loading
1Y
6.0%
7D
-1.3%

Upward revisions to Xylem's revenue growth forecasts and net profit margins have driven an increase in the consensus analyst price target from $145.31 to $157.31.


What's in the News


  • Xylem raised its 2025 revenue guidance to $8.9–9.0 billion, now expecting 4–5% reported growth versus prior 1–2% guidance.
  • Reported $4 million in intangible asset impairment charges for Q2.
  • Dropped from the Russell 1000 Dynamic Index.
  • Manchester City Football Club is expanding its use of Xylem's digital water solutions to improve rainwater capture and reuse, supporting water sustainability goals and fan engagement initiatives.

Valuation Changes


Summary of Valuation Changes for Xylem

  • The Consensus Analyst Price Target has risen from $145.31 to $157.31.
  • The Consensus Revenue Growth forecasts for Xylem has significantly risen from 4.6% per annum to 5.2% per annum.
  • The Net Profit Margin for Xylem has risen from 12.88% to 13.73%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.